Industry Outlook and Trend Analysis
The Thrombectomy Devices Market was worth USD 0.76 billion in 2014 and is expected to reach approximately USD 1.27 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 5.95% during the forecast period. As indicated by the World Health Organization (WHO), cerebrovascular accident or stroke is the second leading reason for death over the world, and this has been a case for a couple of decades now. Subsequently, constant research and developments have been completed and as of late, they have prompted propelled thrombectomy devices, which are used for the expulsion of clots that are hindering the blood flow. The demand in the worldwide thrombectomy devices is anticipated to increase at a significant CAGR amid the gauge time, picking up footing from various different factors, for example, good medical reimbursement policies in the developed nations, developing inclination of minimally invasive methods, extending use of ultrasound in vascular treatment, and procurement of little specific healing centres by tier-1 hospitals.
Product Outlook and Trend Analysis
On the basis of product, the global thrombectomy devices market is segmented into mechanical, aspiration, hydrodynamic, and ultrasonic. In 2017, the aspiration thrombectomy devices segment represented 28.6% of the overall demand and is foreseen to be the leading segment of the thrombectomy devices market throughout the forecast period.
End User Outlook and Trend Analysis
On the basis of application, the market for thrombectomy devices has been bifurcated into clinics, hospitals, ambulatory surgical centres (ASCs), and others. Hospitals keep on providing for the most prominent part of demand; nonetheless, ASCs portion is encountering predictable development in the developed nations as they offer assistance on quick premise, continuous headways in minimally invasive surgical systems, and rising interest for miniaturized therapeutic devices.
Regional Outlook and Trend Analysis
Geographically, thrombectomy devices have the highest demand in North America, especially in the made country of the U.S., owing segments, for instance, to creating determination of mechanically impelled thrombectomy items, extended number of hospital trials, powerful medicinal services foundation, and reimbursement approaches. The APEJ thrombectomy devices market is driven by expanding social insurance use in the rising economies, for example, India, China, and Japan, increment in localized manufacturing, strengthening of distribution networks by means of coordinated efforts, rising awareness among specialists with respect to the advantages offered by these devices.
The leading players in the market are Boston Scientific, Teleflex, Penumbra, Terumo Corporation, Stryker Corporation, Medtronic and Argon Medical Devices Inc. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
The Thrombectomy Devices Market is segmented as follows-
Ambulatory Surgical Centres
Rest of Europe
Rest of Asia-Pacific
Rest of South America
Middle East and Africa
Rest of MEA
Some of the key questions answered by the report are:
What was the market size in 2014 and forecast from 2015 to 2023?
What will be the industry market growth from 2015 to 2023?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?